Publications

  1. Yang B, Bledsoe IO, Deutsch S, Mikhael D, Riemer S, Wiltshire A, Wang S, Reid L, Starr PA, Graham SJ, San Luciano M, Morrison MA. Cerebellar DBS during fMRI: initial findings and simulation-informed thermal assessment. AJNR Am J Neuroradiol. 2026 Mar 12;. doi: 10.3174/ajnr.A9208. [Epub ahead of print] PubMed PMID: 41819793.
  2. Fekri Azgomi H, Louie KH, Bath JE, Presbrey KN, Balakid JP, Marks JH, Wozny TA, Galifianakis NB, San Luciano M, Little S, Starr PA, Wang DD. Modeling and optimizing deep brain stimulation to enhance gait in Parkinson's disease: personalized treatment with neurophysiological insights. NPJ Parkinsons Dis. 2025 Jun 18;11(1):173. doi: 10.1038/s41531-025-00990-5. PubMed PMID: 40533464; PubMed Central PMCID: PMC12177069.
  3. Hoang PT, Bledsoe IO, San Luciano M. Abrupt and Severe Onset of Dystonia, Chorea and Hemiplegic Episodes in a Young Boy with a Novel Heterozygous Missense Variant in the GTPase Domain of RHOBTB2. Mov Disord Clin Pract. 2025 Aug;12 Suppl 2(Suppl 2):S13-S15. doi: 10.1002/mdc3.70116. Epub 2025 May 7. PubMed PMID: 40329844; PubMed Central PMCID: PMC12372597.
  4. Rodriguez-Antiguedad J, Rajalingam R, Krüger C, Teixeira-Dos-Santos D, Sun C, Fernandez-Toledo E, Duarte A, Saffie-Awad P, Barrett MJ, Flanigan JL, Emamikhah M, Patel N, San Luciano M, Cooper C, Bahr N, Oguh O, Buhrmann A, Vater M, Fuchshofen R, Vulinovic F, Parreidt MI, Weissbach A, Lohmann K, Klein C, Marras C, Camargos S. Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review. Int J Mol Sci. 2025 Apr 25;26(9). doi: 10.3390/ijms26094074. PubMed PMID: 40362326; PubMed Central PMCID: PMC12071818.
  5. Johnson KA, Giordano JJ, Ramirez-Zamora A, San Luciano M, Miocinovic S, Okun MS, Wong JK. Editorial: Deep brain stimulation think tank: updates in neurotechnology and neuromodulation, volume IV. Front Hum Neurosci. 2024;18:1441212. doi: 10.3389/fnhum.2024.1441212. eCollection 2024. PubMed PMID: 38993328; PubMed Central PMCID: PMC11236721.
  6. San Luciano M, Oehrn CR, Wang SS, Tolmie JS, Wiltshire A, Graff RE, Zhu J, Starr PA. Protocol for combined N-of-1 trials to assess cerebellar neurostimulation for movement disorders in children and young adults with dyskinetic cerebral palsy. BMC Neurol. 2024 Apr 29;24(1):145. doi: 10.1186/s12883-024-03633-z. PubMed PMID: 38684956; PubMed Central PMCID: PMC11057158.
  7. Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson's disease. Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8. Review. PubMed PMID: 38245248; PubMed Central PMCID: PMC11123577.
  8. Cajigas I, Morrison MA, San Luciano M, Starr P. Cerebellar Deep Brain Stimulation in Cerebral Palsy: Promising Early Results and a Look Forward to a Larger Clinical Trial. World Neurosurg. 2023 Jun;174:223-224. doi: 10.1016/j.wneu.2023.03.069. Epub 2023 Mar 20. PubMed PMID: 36940804; PubMed Central PMCID: PMC10691838.
  9. Duffley G, Szabo A, Lutz BJ, Mahoney-Rafferty EC, Hess CW, Ramirez-Zamora A, Zeilman P, Foote KD, Chiu S, Pourfar MH, Goas Cnp C, Wood JL, Haq IU, Siddiqui MS, Afshari M, Heiry M, Choi J, Volz M, Ostrem JL, San Luciano M, Niemann N, Billnitzer A, Savitt D, Tarakad A, Jimenez-Shahed J, Aquino CC, Okun MS, Butson CR. Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial. Parkinsonism Relat Disord. 2023 Apr;109:105346. doi: 10.1016/j.parkreldis.2023.105346. Epub 2023 Mar 16. PubMed PMID: 36966051; PubMed Central PMCID: PMC11265292.
  10. Cajigas I, Morrison MA, Luciano MS, Starr PA. Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy. J Neurosurg. 2023 Sep 1;139(3):605-614. doi: 10.3171/2023.1.JNS222289. Print 2023 Sep 1. PubMed PMID: 36789999; PubMed Central PMCID: PMC10726727.
  11. Wong JK, Mayberg HS, Wang DD, Richardson RM, Halpern CH, Krinke L, Arlotti M, Rossi L, Priori A, Marceglia S, Gilron R, Cavanagh JF, Judy JW, Miocinovic S, Devergnas AD, Sillitoe RV, Cernera S, Oehrn CR, Gunduz A, Goodman WK, Petersen EA, Bronte-Stewart H, Raike RS, Malekmohammadi M, Greene D, Heiden P, Tan H, Volkmann J, Voon V, Li L, Sah P, Coyne T, Silburn PA, Kubu CS, Wexler A, Chandler J, Provenza NR, Heilbronner SR, Luciano MS, Rozell CJ, Fox MD, de Hemptinne C, Henderson JM, Sheth SA, Okun MS. Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation. Front Hum Neurosci. 2022;16:1084782. doi: 10.3389/fnhum.2022.1084782. eCollection 2022. PubMed PMID: 36819295; PubMed Central PMCID: PMC9933515.
  12. Leaver K, Viser A, Kopell BH, Ortega RA, Miravite J, Okun MS, Elango S, Raymond D, Bressman SB, Saunders-Pullman R, Luciano MS. Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease. J Neurosurg. 2022 Jul 1;137(1):184-191. doi: 10.3171/2021.7.JNS21190. Print 2022 Jul 1. PubMed PMID: 34798606; PubMed Central PMCID: PMC9117559.
  13. de Hemptinne C, Chen W, Racine CA, Seritan AL, Miller AM, Yaroshinsky MS, Wang SS, Gilron R, Little S, Bledsoe I, San Luciano M, Katz M, Chang EF, Dawes HE, Ostrem JL, Starr PA. Prefrontal Physiomarkers of Anxiety and Depression in Parkinson's Disease. Front Neurosci. 2021;15:748165. doi: 10.3389/fnins.2021.748165. eCollection 2021. PubMed PMID: 34744613; PubMed Central PMCID: PMC8568318.
  14. Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, Racine CA, Wang SS, Ostrem JL, Larson PS, Wang DD, Galifianakis NB, Bledsoe IO, San Luciano M, Dawes HE, Worrell GA, Kremen V, Borton DA, Denison T, Starr PA. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease. Nat Biotechnol. 2021 Sep;39(9):1078-1085. doi: 10.1038/s41587-021-00897-5. Epub 2021 May 3. PubMed PMID: 33941932; PubMed Central PMCID: PMC8434942.
  15. Greene KA, Lu V, Luciano MS, Qubty W, Irwin SL, Grimes B, Gelfand AA. Benign paroxysmal torticollis: phenotype, natural history, and quality of life. Pediatr Res. 2021 Nov;90(5):1044-1051. doi: 10.1038/s41390-020-01309-1. Epub 2021 Feb 9. PubMed PMID: 33564129; PubMed Central PMCID: PMC8349923.
  16. San Luciano M, Robichaux-Viehoever A, Dodenhoff KA, Gittings ML, Viser AC, Racine CA, Bledsoe IO, Watson Pereira C, Wang SS, Starr PA, Ostrem JL. Thalamic deep brain stimulation for acquired dystonia in children and young adults: a phase 1 clinical trial. J Neurosurg Pediatr. 2021 Feb 1;27(2):203-212. doi: 10.3171/2020.7.PEDS20348. Print 2021 Feb 1. PubMed PMID: 33254134; PubMed Central PMCID: PMC8155109.
  17. Bledsoe IO, Viser AC, San Luciano M. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation. Neurotherapeutics. 2020 Oct;17(4):1622-1644. doi: 10.1007/s13311-020-00944-0. Epub 2020 Oct 23. Review. PubMed PMID: 33095402; PubMed Central PMCID: PMC7851280.
  18. San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance. Mov Disord. 2020 Oct;35(10):1755-1764. doi: 10.1002/mds.28189. Epub 2020 Jul 14. PubMed PMID: 32662532; PubMed Central PMCID: PMC7572560.
  19. Vitek JL, Jain R, Chen L, Tröster AI, Schrock LE, House PA, Giroux ML, Hebb AO, Farris SM, Whiting DM, Leichliter TA, Ostrem JL, San Luciano M, Galifianakis N, Verhagen Metman L, Sani S, Karl JA, Siddiqui MS, Tatter SB, Ul Haq I, Machado AG, Gostkowski M, Tagliati M, Mamelak AN, Okun MS, Foote KD, Moguel-Cobos G, Ponce FA, Pahwa R, Nazzaro JM, Buetefisch CM, Gross RE, Luca CC, Jagid JR, Revuelta GJ, Takacs I, Pourfar MH, Mogilner AY, Duker AP, Mandybur GT, Rosenow JM, Cooper SE, Park MC, Khandhar SM, Sedrak M, Phibbs FT, Pilitsis JG, Uitti RJ, Starr PA. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. Lancet Neurol. 2020 Jun;19(6):491-501. doi: 10.1016/S1474-4422(20)30108-3. Epub 2020 May 26. PubMed PMID: 32470421.
  20. Bledsoe IO, Dodenhoff KA, San Luciano M, Volz MM, Starr PA, Markun LC, Ostrem JL. Phenomenology and Management of Subthalamic Stimulation-Induced Dyskinesia in Patients With Isolated Dystonia. Mov Disord Clin Pract. 2020 Jul;7(5):548-551. doi: 10.1002/mdc3.12946. eCollection 2020 Jul. PubMed PMID: 32626800; PubMed Central PMCID: PMC7328432.
  21. Rajagopalan SS, Miller AM, de Hemptinne C, San Luciano M, Ostrem JL, Starr PA. Washout of chronic therapeutic deep brain stimulation increases cortical phase-amplitude coupling. Parkinsonism Relat Disord. 2019 Sep;66:269-271. doi: 10.1016/j.parkreldis.2019.08.018. Epub 2019 Aug 27. PubMed PMID: 31477410; PubMed Central PMCID: PMC7376959.
  22. Agalliu I, Ortega RA, Luciano MS, Mirelman A, Pont-Sunyer C, Brockmann K, Vilas D, Tolosa E, Berg D, Warø B, Glickman A, Raymond D, Inzelberg R, Ruiz-Martinez J, Mondragon E, Friedman E, Hassin-Baer S, Alcalay RN, Mejia-Santana H, Aasly J, Foroud T, Marder K, Giladi N, Bressman S, Saunders-Pullman R. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls. Mov Disord. 2019 Sep;34(9):1392-1398. doi: 10.1002/mds.27807. Epub 2019 Jul 26. PubMed PMID: 31348549; PubMed Central PMCID: PMC6754269.
  23. Mitchell KT, Volz M, Lee A, San Luciano M, Wang S, Starr PA, Larson P, Galifianakis NB, Ostrem JL. Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders. Stereotact Funct Neurosurg. 2019;97(2):113-119. doi: 10.1159/000500993. Epub 2019 Jul 9. PubMed PMID: 31288242; PubMed Central PMCID: PMC6689445.
  24. Sarva H, Trosch R, Kiss ZHT, Furtado S, Luciano MS, Glickman A, Raymond D, Ozelius LJ, Bressman SB, Saunders-Pullman R. Deep Brain Stimulation in Isolated Dystonia With a GNAL Mutation. Mov Disord. 2019 Feb;34(2):301-303. doi: 10.1002/mds.27585. Epub 2018 Dec 10. PubMed PMID: 30536916; PubMed Central PMCID: PMC6659994.
  25. Wang DD, de Hemptinne C, Miocinovic S, Ostrem JL, Galifianakis NB, San Luciano M, Starr PA. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease. J Neurosci. 2018 May 9;38(19):4556-4568. doi: 10.1523/JNEUROSCI.0431-18.2018. Epub 2018 Apr 16. PubMed PMID: 29661966; PubMed Central PMCID: PMC5943981.
  26. Southwell DG, Rutkowski MJ, San Luciano M, Racine C, Ostrem J, Starr PA, Larson PS. Before and after the veterans affairs cooperative program 468 study: Deep brain stimulator target selection for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2018 Mar;48:40-44. doi: 10.1016/j.parkreldis.2017.12.013. Epub 2017 Dec 12. PubMed PMID: 29249683.
  27. San Luciano M, Wang C, Ortega RA, Giladi N, Marder K, Bressman S, Saunders-Pullman R. Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease. Ann Clin Transl Neurol. 2017 Nov;4(11):801-810. doi: 10.1002/acn3.489. eCollection 2017 Nov. PubMed PMID: 29159192; PubMed Central PMCID: PMC5682117.
  28. LaHue SC, Ostrem JL, Galifianakis NB, San Luciano M, Ziman N, Wang S, Racine CA, Starr PA, Larson PS, Katz M. Parkinson's disease patient preference and experience with various methods of DBS lead placement. Parkinsonism Relat Disord. 2017 Aug;41:25-30. doi: 10.1016/j.parkreldis.2017.04.010. Epub 2017 Apr 17. PubMed PMID: 28615151.
  29. Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Ostrem JL, Galifianakis NB, Luciano MS, Wang SS, Ziman N, Taylor R, Starr PA. Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's disease. J Neurosurg. 2018 Feb;128(2):605-616. doi: 10.3171/2016.11.JNS161162. Epub 2017 Apr 14. PubMed PMID: 28409730; PubMed Central PMCID: PMC5641233.
  30. Ostrem JL, San Luciano M, Dodenhoff KA, Ziman N, Markun LC, Racine CA, de Hemptinne C, Volz MM, Heath SL, Starr PA. Subthalamic nucleus deep brain stimulation in isolated dystonia: A 3-year follow-up study. Neurology. 2017 Jan 3;88(1):25-35. doi: 10.1212/WNL.0000000000003451. Epub 2016 Nov 30. PubMed PMID: 27903810.
  31. San Luciano M, Wang C, Ortega RA, Yu Q, Boschung S, Soto-Valencia J, Bressman SB, Lipton RB, Pullman S, Saunders-Pullman R. Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease. PLoS One. 2016;11(10):e0162799. doi: 10.1371/journal.pone.0162799. eCollection 2016. PubMed PMID: 27732597; PubMed Central PMCID: PMC5061372.
  32. Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Wang SS, Ziman N, Ostrem JL, San Luciano M, Galifianakis NB, Starr PA. Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease. J Neurosci. 2016 Jun 15;36(24):6445-58. doi: 10.1523/JNEUROSCI.1128-16.2016. PubMed PMID: 27307233; PubMed Central PMCID: PMC5015781.
  33. Wang DD, de Hemptinne C, Miocinovic S, Qasim SE, Miller AM, Ostrem JL, Galifianakis NB, San Luciano M, Starr PA. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers. Neurobiol Dis. 2016 May;89:213-22. doi: 10.1016/j.nbd.2016.02.015. Epub 2016 Feb 14. PubMed PMID: 26884091; PubMed Central PMCID: PMC4790450.
  34. Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, Racine CA, Martin AJ, Markun LC, Larson PS. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. J Neurosurg. 2016 Apr;124(4):908-16. doi: 10.3171/2015.4.JNS15173. Epub 2015 Oct 23. PubMed PMID: 26495947.
  35. Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, Luciano MS, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N, Johannes B, Yasinovsky K, Ozelius L, Clark L, Orr-Utreger A, Marder K, Giladi N, Bressman SB. REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord. 2015 Nov;30(13):1834-9. doi: 10.1002/mds.26413. Epub 2015 Sep 14. PubMed PMID: 26366513; PubMed Central PMCID: PMC4715645.
  36. Marder K, Wang Y, Alcalay RN, Mejia-Santana H, Tang MX, Lee A, Raymond D, Mirelman A, Saunders-Pullman R, Clark L, Ozelius L, Orr-Urtreger A, Giladi N, Bressman S. Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium. Neurology. 2015 Jul 7;85(1):89-95. doi: 10.1212/WNL.0000000000001708. Epub 2015 Jun 10. PubMed PMID: 26062626; PubMed Central PMCID: PMC4501942.
  37. de Hemptinne C, Swann NC, Ostrem JL, Ryapolova-Webb ES, San Luciano M, Galifianakis NB, Starr PA. Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci. 2015 May;18(5):779-86. doi: 10.1038/nn.3997. Epub 2015 Apr 13. PubMed PMID: 25867121; PubMed Central PMCID: PMC4414895.
  38. Katz M, Luciano MS, Carlson K, Luo P, Marks WJ Jr, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Ann Neurol. 2015 Apr;77(4):710-9. doi: 10.1002/ana.24374. PubMed PMID: 25627340.
  39. Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973. PubMed PMID: 25401981; PubMed Central PMCID: PMC4366130.
  40. Saunders-Pullman R, Mirelman A, Wang C, Alcalay RN, San Luciano M, Ortega R, Raymond D, Mejia-Santana H, Ozelius L, Clark L, Orr-Utreger A, Marder K, Giladi N, Bressman SB. Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?. Ann Clin Transl Neurol. 2014 Sep;1(9):670-8. doi: 10.1002/acn3.95. Epub 2014 Sep 30. PubMed PMID: 25493281; PubMed Central PMCID: PMC4241794. 
  41. Mills KA, Markun LC, San Luciano M, Rizk R, Allen IE, Racine CA, Starr PA, Alberts JL, Ostrem JL. Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia. J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):404-9. doi: 10.1136/jnnp-2014-307942. Epub 2014 Jul 10. PubMed PMID: 25012202; PubMed Central PMCID: PMC4392192.
  42. Liu J, Jiang X, Ishii S, Shalaev V, Irudayaraj J. Quantifying local density of optical states of nanorods by fluorescence lifetime imaging. New J Phys. 2014 Jun;16:063069. doi: 10.1088/1367-2630/16/6/063069. PubMed PMID: 25408619; PubMed Central PMCID: PMC4232967.
  43. Karakis I, Cole AJ, Montouris GD, San Luciano M, Meador KJ, Piperidou C. Caregiver burden in epilepsy: determinants and impact. Epilepsy Res Treat. 2014;2014:808421. doi: 10.1155/2014/808421. Epub 2014 Apr 8. PubMed PMID: 24808956; PubMed Central PMCID: PMC3997889.
  44. Saunders-Pullman R, Fuchs T, San Luciano M, Raymond D, Brashear A, Ortega R, Deik A, Ozelius LJ, Bressman SB. Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites. Mov Disord. 2014 May;29(6):812-8. doi: 10.1002/mds.25818. Epub 2014 Feb 5. PubMed PMID: 24500857; PubMed Central PMCID: PMC4013240.
  45. Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, Barrett MJ, Cabassa J, Groves M, Hunt AL, Lubarr N, San Luciano M, Miravite J, Palmese C, Sachdev R, Sarva H, Severt L, Shanker V, Swan MC, Soto-Valencia J, Johannes B, Ortega R, Fahn S, Cote L, Waters C, Mazzoni P, Ford B, Louis E, Levy O, Rosado L, Ruiz D, Dorovski T, Pauciulo M, Nichols W, Orr-Urtreger A, Ozelius L, Clark L, Giladi N, Bressman S, Marder KS. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord. 2013 Dec;28(14):1966-71. doi: 10.1002/mds.25647. Epub 2013 Oct 15. PubMed PMID: 24243757; PubMed Central PMCID: PMC3859844.
  46. Karakis I, Montouris GD, Piperidou C, Luciano MS, Meador KJ, Cole AJ. Patient and caregiver quality of life in psychogenic non-epileptic seizures compared to epileptic seizures. Seizure. 2014 Jan;23(1):47-54. doi: 10.1016/j.seizure.2013.09.011. Epub 2013 Sep 25. PubMed PMID: 24140136.
  47. Karakis I, Montouris GD, Piperidou C, Luciano MS, Meador KJ, Cole AJ. The effect of epilepsy surgery on caregiver quality of life. Epilepsy Res. 2013 Nov;107(1-2):181-9. doi: 10.1016/j.eplepsyres.2013.08.006. Epub 2013 Sep 2. PubMed PMID: 24054427.
  48. Katz M, Byl NN, San Luciano M, Ostrem JL. Focal task-specific lower extremity dystonia associated with intense repetitive exercise: a case series. Parkinsonism Relat Disord. 2013 Nov;19(11):1033-8. doi: 10.1016/j.parkreldis.2013.07.013. Epub 2013 Aug 9. Review. PubMed PMID: 23932354.
  49. Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Hervé D, Sharma N, Ehrlich ME, Martemyanov KA, Bressman SB, Ozelius LJ. Mutations in GNAL cause primary torsion dystonia. Nat Genet. 2013 Jan;45(1):88-92. doi: 10.1038/ng.2496. Epub 2012 Dec 9. PubMed PMID: 23222958; PubMed Central PMCID: PMC3530620.
  50. Deik AF, O'Riordan S, Luciano MS, Shanker VL, Raymond D, Bressman SB, Saunders-Pullman R. Spatial Discrimination Threshold Abnormalities are not Detected in a Pilot Study of DYT6 Dystonia Mutation Carriers. Tremor Other Hyperkinet Mov (N Y). 2012;2. doi: 10.7916/D8PR7TPC. Epub 2012 Sep 17. PubMed PMID: 23439738; PubMed Central PMCID: PMC3570067.
  51. Deik A, Saunders-Pullman R, Luciano MS. Substance of abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243. Review. PubMed PMID: 23030352; PubMed Central PMCID: PMC3966544. 
  52. Deik A, Saunders-Pullman R, Luciano MS. Substance of abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243. Review. PubMed PMID: 23030352; PubMed Central PMCID: PMC3966544.
  53. Karakis I, Chiappa KH, San Luciano M, Sassower KC, Stakes JW, Cole AJ. The utility of routine EEG in the diagnosis of sleep disordered breathing. J Clin Neurophysiol. 2012 Aug;29(4):333-8. doi: 10.1097/WNP.0b013e31826244ae. PubMed PMID: 22854767.
  54. Saunders-Pullman R, Raymond D, Stoessl AJ, Hobson D, Nakamura K, Nakamura T, Pullman S, Lefton D, Okun MS, Uitti R, Sachdev R, Stanley K, San Luciano M, Hagenah J, Gatti R, Ozelius LJ, Bressman SB. Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology. 2012 Feb 28;78(9):649-57. doi: 10.1212/WNL.0b013e3182494d51. Epub 2012 Feb 15. PubMed PMID: 22345219; PubMed Central PMCID: PMC3286230.
  55. San Luciano M, Ozelius L, Lipton RB, Raymond D, Bressman SB, Saunders-Pullman R. Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease. Neurosci Lett. 2012 Jan 11;506(2):312-6. doi: 10.1016/j.neulet.2011.11.032. Epub 2011 Dec 1. PubMed PMID: 22155094; PubMed Central PMCID: PMC3249002.
  56. Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, Severt L, Raymond D, Ozelius LJ, Lipton RB, Bressman SB. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology. 2011 Jul 26;77(4):319-24. doi: 10.1212/WNL.0b013e318227041c. Epub 2011 Jul 13. PubMed PMID: 21753159; PubMed Central PMCID: PMC3140803.
  57. Saunders-Pullman R, Stanley K, San Luciano M, Barrett MJ, Shanker V, Raymond D, Ozelius LJ, Bressman SB. Gender differences in the risk of familial parkinsonism: beyond LRRK2?. Neurosci Lett. 2011 Jun 1;496(2):125-8. doi: 10.1016/j.neulet.2011.03.098. Epub 2011 Apr 12. PubMed PMID: 21511009; PubMed Central PMCID: PMC3111955.
  58. Saunders-Pullman R, Cabassa J, San Luciano M, Stanley K, Raymond D, Ozelius LJ, Bressman SB. LRRK2 G2019S mutations may be increased in Puerto Ricans. Mov Disord. 2011 Aug 1;26(9):1772-3. doi: 10.1002/mds.23632. Epub 2011 Mar 29. PubMed PMID: 21449009; PubMed Central PMCID: PMC3140626.
  59. San Luciano M, Lipton RB, Wang C, Katz M, Zimmerman ME, Sanders AE, Ozelius LJ, Bressman SB, Saunders-Pullman R. Clinical expression of LRRK2 G2019S mutations in the elderly. Mov Disord. 2010 Nov 15;25(15):2571-6. doi: 10.1002/mds.23330. PubMed PMID: 20721910; PubMed Central PMCID: PMC2978804.
  60. Saunders-Pullman R, Barrett MJ, Stanley KM, Luciano MS, Shanker V, Severt L, Hunt A, Raymond D, Ozelius LJ, Bressman SB. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Mov Disord. 2010 Nov 15;25(15):2536-41. doi: 10.1002/mds.23314. PubMed PMID: 20818610; PubMed Central PMCID: PMC2978749.
  61. Saunders-Pullman R, Stanley K, Brüggemann N, Raymond D, San Luciano M, Wang C, Klein C, Lubarr N, Ozelius L, Bressman SB, Hagenah J. Substantia nigra hyperechogenicity in DYT6 dystonia: a pilot study. Parkinsonism Relat Disord. 2010 Jul;16(6):420-2. doi: 10.1016/j.parkreldis.2010.03.003. Epub 2010 Apr 22. PubMed PMID: 20417146; PubMed Central PMCID: PMC2916033.
  62. Kurtis MM, San Luciano M, Yu Q, Goodman RR, Ford B, Raymond D, Pullman SL, Saunders-Pullman R. Clinical and neurophysiological improvement of SGCE myoclonus-dystonia with GPi deep brain stimulation. Clin Neurol Neurosurg. 2010 Feb;112(2):149-52. doi: 10.1016/j.clineuro.2009.10.001. Epub 2009 Nov 5. PubMed PMID: 19896264; PubMed Central PMCID: PMC2815107.
  63. San Luciano M, Saunders-Pullman R. Substance abuse and movement disorders. Curr Drug Abuse Rev. 2009 Sep;2(3):273-8. doi: 10.2174/1874473710902030273. Review. PubMed PMID: 20443774.
  64. Luciano MS, Ozelius L, Sims K, Raymond D, Liu L, Saunders-Pullman R. Responsiveness to levodopa in epsilon-sarcoglycan deletions. Mov Disord. 2009 Feb 15;24(3):425-8. doi: 10.1002/mds.22375. PubMed PMID: 19133653.
  65. Mengual E, Chan J, Lane D, San Luciano Palenzuela M, Hara Y, Lessard A, Pickel VM. Neurokinin-1 receptors in cholinergic neurons of the rat ventral pallidum have a predominantly dendritic distribution that is affected by apomorphine when combined with startle-evoking auditory stimulation. Neuroscience. 2008 Feb 6;151(3):711-24. doi: 10.1016/j.neuroscience.2007.08.039. Epub 2007 Dec 4. PubMed PMID: 18178320; PubMed Central PMCID: PMC2268874.
  66. Marta S, Shanker VL, Bressman SB, Raymond D, Saunders-Pullman R. Pregnancy and Delivery Complications in Women with Inherited Isolated Dystonia. International Congress of Parkinson and Movement Disorders; 2019 September 22; Nice, France.